A carregar...
Simplified steps to heterologous prime-boost HIV vaccine development?
The RV 144 HIV vaccine efficacy study showed a reduction in HIV-1 infection risk in Thai volunteers who received two priming vaccinations of vCP1521 ALVAC (attenuated recombinant canarypox virus expressing HIV group–specific antigen, polymerase, and envelope genes) followed by two additional ALVAC v...
Na minha lista:
| Publicado no: | J Clin Invest |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society for Clinical Investigation
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6819123/ https://ncbi.nlm.nih.gov/pubmed/31566582 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI132440 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|